COX-2 Inhibitors Contraindicated For Heart Disease Patients In Europe
This article was originally published in The Pink Sheet Daily
Executive Summary
European Medicines Agency says COX-2 inhibitors should not be used in individuals with ischemic heart disease or stroke and recommends caution when prescribing the drugs for patients with risk factors for heart disease. Agency also adds a hypertension contraindication for Merck’s Arcoxia.